PSYENCE BIOMEDICAL LTD (PBM)
CA74449F1009 - Common Stock
PSYENCE BIOMEDICAL LTD
NASDAQ:PBM (11/22/2024, 8:00:02 PM)
After market: 0.0422 0 (-2.99%)0.0435
0 (-7.45%)
Company Profile
Psyence Biomedical Ltd. is a life science biotechnology company. The company is headquartered in Toronto, Ontario. The company went IPO on 2021-12-10. The firm has partnered with iNGENu Pty Ltd (iNGENu) to conduct the Company’s clinical trial in palliative care. iNGENu is an Australia-based, globally focused contract research organization (CRO) with experience working in the psychedelic pharmaceutical drug development and clinical research industry. Its Phase IIb clinical trial, using PEX010, a 25mg naturally derived psilocybin drug candidate product in-licensed by the Company, in the palliative care setting.
Company Info
PSYENCE BIOMEDICAL LTD
121 Richmond Street West Penthouse, Suite 1300
TORONTO ONTARIO V6E 3Z3
P: 17744604171
CEO: John Plourde
Employees: 0
Website: http://psyence.com
PBM News
4 days ago - Psyence Biomedical Ltd.Psyence Biomedical Announces Favorable Result of Nasdaq Listing Qualifications HearingNEW YORK, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed” or the “Company”) today announced the favorable...
5 days ago - Psyence Biomedical Ltd.Psyence Biomedical Announces Effective Date for 1-for-75 Share ConsolidationNEW YORK, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed” or the “Company”) today announced an effective date...
11 days ago - ChartmillDiscover the top movers in Wednesday's pre-market session and stay informed about market dynamics.Get insights into the top gainers and losers of Wednesday's pre-market session.
12 days ago - Psyence Biomedical Ltd.Psyence Biomedical Announces Results from Annual and Special General Meeting, Share Consolidation and Receipt of Additional Staff Determination from NasdaqNEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed” or the “Company”) today announced the voting results...
24 days ago - Psyence Group Inc.Psyence Group Announces Closing of Previously Announced Disposal of its Stake in PsyLabsPsyLabs develops and produces certified pharmaceutical-grade nature-derived psychedelics for applications in mental health and well-being Psyence...
24 days ago - Psyence Biomedical Ltd.Psyence Biomedical Announces Closing of Previously Announced Acquisition of Psyence Group’s Stake in PsyLabsPsyLabs develops and produces certified pharmaceutical-grade nature-derived psychedelics for applications in mental health and well-being ...
PBM Twits
Here you can normally see the latest stock twits on PBM, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
